Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis

19 May 2025 (09:00 - 09:45)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Associate Professor Alexandros Briasoulis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

3 More presentations in this session

Presentation thumbnail

Differences in heart failure with preserved ejection fraction diagnostic and therapeutic practices between physicians from europe and the middle east and north africa: an international survey

Professor H. Alarfaj (Riyadh, SA)

Abstract Slides Video

Presentation thumbnail

Peroxiredoxin-4 and beta-hydroxybutyrate after SGLT2 inhibitor treatment in heart failure with preserved ejection fraction

Miss A. Achten (Maastricht, NL)

Abstract Slides Video

Presentation thumbnail

Incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: the single centre experience

Assistant Professor M. Pandrc (Belgrade, RS)

Abstract Slides Video

Access the full session

Session thumbnail

Diagnosis and prognosis of HFpEF

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET

You may be interested in

Congress Presentation

Prevalence of frailty and standard geriatric syndromes in hospitalized patients with acute decompensated heart failure

Congress Presentation

Multiple comorbidities are associated with poor prognosis in patients with ADHF-HFpEF and non-frailty or mild frailty but not moderate-severe frailty -PURSUIT-HFpEF Registry-

Congress Presentation

Prognostic impact of multimorbidity and frailty on 90-day survival in older patients hospitalised for acute heart failure: a prospective study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources